The number of people with susceptibility test result for rifampicin in France

France: The number of people with susceptibility test result for rifampicin was 17 in 2021. ◆ Volatile

Latest (2021)
17
Change on year
down 15.0%
World rank
134th
of 155 countries
All-time high
2,753
in 2018
All-time low
17
in 2021
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in France, 2017–2021

01.0k2.0k3.0k2017201920212017: 2.6k2018: 2.8k2019: 202020: 202021: 17

Source: World Health Organization, Global Health Observatory.

Analysis

France recorded 17 for the number of people with susceptibility test result for rifampicin in 2021. That is the lowest value across all 5 years on record.

The figure is down 15.0% on the previous year and down 99.4% over five years.

That places France 134th out of 155 countries with data for 2021, putting it in the bottom quarter.

The number of people with susceptibility test result for rifampicin in France, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in France, 2017 to 2021.
Year Value Change
2017 2,630
2018 2,753 +4.7%
2019 20 -99.3%
2020 20 +0.0%
2021 17 -15.0%

France compared with similar countries

  • France's 17 is below the median for high income countries, which is 142, 12% of the median. (61 countries reporting)
  • France's 17 is below the median for Europe & Central Asia, which is 229.5, 7% of the median. (44 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 1,801 20 2,753 3
2020s 18.5 17 20 2

Countries ranked near France

  1. 131 United Arab Emirates 23 compare
  2. 132 Luxembourg 21 compare
  3. 133 Tuvalu 19 compare
  4. 135 New Caledonia 15 compare
  5. 136 Puerto Rico 14 compare
  6. 136 Naoero 14 compare

See the full ranking of 157 places →

More health data for France

All data for France →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in France?
The number of people with susceptibility test result for rifampicin in France was 17 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in France?
The highest recorded value was 2,753 in 2018.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in France?
The lowest recorded value was 17 in 2021.
How does France rank for the number of people with susceptibility test result for rifampicin?
France ranks 134th out of 155 countries with data for 2021.
Where does this France data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in France. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 15 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/france/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/france/">The number of people with susceptibility test result for rifampicin in France</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed